As of January 23, 2025, Dr Lal PathLabs (LALPATHLAB.NS) has a market cap of $2.74 billion USD. According to our data, Dr Lal PathLabs is ranked No.3620 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $2.74 B |
-5.21%
|
Dec 31, 2024 | $2.89 B |
17.66%
|
Dec 29, 2023 | $2.46 B |
14.62%
|
Dec 30, 2022 | $2.14 B |
-40.54%
|
Dec 31, 2021 | $3.61 B |
66.87%
|
Dec 31, 2020 | $2.16 B |
55.28%
|
Dec 31, 2019 | $1.39 B |
65.80%
|
Dec 31, 2018 | $0.84 B |
4.27%
|
Dec 29, 2017 | $0.80 B |
-17.30%
|
Dec 30, 2016 | $0.97 B |
33.46%
|
Dec 31, 2015 | $0.73 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Quest Diagnostics
DGX
|
$16.91 B |
-0.000 M
|
USA
|
LabCorp
LH
|
$20.28 B |
0.001 M
|
USA
|
Sea (Garena)
SE
|
$67.98 B |
5.389 B
|
Singapore
|
OPKO Health
OPK
|
$0.99 B |
-0.000 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Fresenius Medical Care
FMS
|
$13.60 B |
-0.000 M
|
Germany
|
Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
Charles River Laboratories
CRL
|
$8.60 B |
-0.000 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
Market Cap | = | LALPATHLAB.NS Stock Price | * | LALPATHLAB.NS Shares Outstanding |
= | $32.89 | * | 83.35 M | |
= | $2.74 B |